Fair Value Measurements (Tables)

12 Months Ended

Dec. 31, 2021

Fair Value Disclosures [Abstract]

Schedule of Financial Instrument Measured on Recurring Basis

	As of December 31, 2021				Fair Value Measurements
	Carrying		Fair		As of December 31, 2021
	Amount		Value		Level 1		Level 2		Level 3
Liabilities:
Contingent consideration:
Asuragen	$	1,871	$	1,871	$	-	$	-	$	1,871
Other accrued expenses:
Warrant liability		71		71		-		-		71
Note payable:
BroadOak loan		7,942		7,942		-		-		7,942
	$	9,884	$	9,884	$	-	$	-	$	9,884

	As of December 31, 2020				Fair Value Measurements
	Carrying		Fair		As of December 31, 2020
	Amount		Value		Level 1		Level 2		Level 3
Liabilities:
Contingent consideration:
Asuragen	$	2,216	$	2,216	$	-	$	-	$	2,216
Other long-term liabilities:
Warrant liability		21		21		-		-		21
	$	2,237	$	2,237	$	-	$	-	$	2,237

Schedule of Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation

										Adjustment
								Accretion/		to Fair Value/
	December 31, 2020		Loan Received		Payments			Interest Accrued		Mark to Market			December 31, 2021
Asuragen	$	2,216			$	(503	)	$	496	$	(338	)	$	1,871
Underwriters Warrants		21				-			-		50			71
BroadOak Loan		-		8,000		-			-		(58	)		7,942
	$	2,237	$	8,000	$	(503	)	$	496	$	(346	)	$	9,884